-

Shareholder Alert: Robbins LLP Reminds Investors that First Solar, Inc. (FSLR) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired shares of First Solar, Inc. (NASDAQ: FSLR) common stock between February 22, 2019 and February 20, 2020. First Solar manufactures solar energy panels and powerplants.

If you suffered a loss due to First Solar, Inc.'s misconduct, click here.

First Solar, Inc. (FSLR) Made Misrepresentations Regarding its Series 6 Solar Module

According to the complaint, First Solar launched a new PV solar panel module, the Series 6, in 2017. First Solar laid out an "aggressive" Series 6 cost per watt reduction target, and touted the success of the Series 6 program. For example, in August 2019, First Solar executives confirmed that the Company had achieved the Series 6 cost per watt objective it had set for the first half of 2019. In October 2019, First Solar claimed that it was "slightly ahead of the roadmap." These and similar statements made throughout the class period were false. In reality, the defendants knew or recklessly disregarded that the Series 6 solar module was not commercially ready at the time of its release, had a component that was failing in the field and causing fires, was not able to hit its projected and touted wattage targets, and had an inconsistent output-all of which put First Solar at a competitive disadvantage.

As news of these deficiencies became known, First Solar's stock price began to decline. Then, on February 20, 2020, First Solar announced that it was exploring a sale of its Project Development business and acknowledged it was experiencing "challenges with regard to certain aspects of the overall cost per watt" and that the Company would not be realizing its cost per watt goals. The Company then stated it would no longer be disclosing a discrete cost per watt for its Series 6 units because customers had "start[ed] to hold [the Company] accountable to a cost-plus model … [a]nd so we have purposely moved away from giving a discrete cost per watt." On this news, First Solar's stock declined $8.73 per share, or nearly 15%, to close at $50.59 per share on February 21, 2021.

If you purchased shares of First Solar, Inc. (FSLR) between February 22, 2019 and February 20, 2020, you have until March 8, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against First Solar, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Contact:
Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom